Mass-Fix for M-protein measurement in multiple myeloma

Traditionally, immunofixation electrophoresis (IFE) has been used to measure immunoglobulins (Igs) from patients with multiple myeloma (MM),...

Which novel agents will benefit frail patients?

During the 2nd European Myeloma Network Meeting, the Multiple Myeloma Hub spoke to Alessandra Larocca, City of Health and Science University Hospital,...

DART4MM study: Can daratumumab consolidation achieve MRD-negativity after frontline therapy?

During the 2nd European Myeloma Network Meeting, the Multiple Myeloma Hub spoke to Alessandro Gozzetti,...

If maintenance after induction reduces therapy options at relapse, is it still worth it?

During the 2nd European Myeloma Network Meeting, the Multiple Myeloma Hub spoke to Professor Graham Jackson,...

What are the major challenges for CAR T-cell therapies in Europe during the COVID-19 pandemic?

During the Virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation...

FDA grants regenerative medicine advanced therapy designation to ALLO-715 for RRMM

On April 21, 2021, it was announced that the U.S. Food and Drug Administration (FDA) granted regenerative medicine...

Moving beyond CAR T-cell therapy: Why is everyone talking about NK-cell therapy?

During the European School of Haematology (ESH) 3rd How to Diagnose and Treat Multiple Myeloma conference, the Multiple...

Results from the KarMMa trial on ide-cel in patients with relapsed/refractory MM

Idecabtagene vicleucel (ide-cel) is a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell...

COVID-19 vaccination for hematopoietic stem cell transplant patients

The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular,...

What are the major challenges for CAR T-cell therapies in Europe during the COVID-19 pandemic?

During the Virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation...

NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies

Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary...

Can lenalidomide maintenance be given to patients with MM and COVID-19 infection?

During the 2nd European Myeloma Network Meeting, the Multiple Myeloma Hub spoke to Meral Beksaç, Ankara University,...